{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:37:06Z","timestamp":1774931826534,"version":"3.50.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T00:00:00Z","timestamp":1279065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s12253-010-9276-4","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T15:00:18Z","timestamp":1279033218000},"page":"141-143","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy of Romiplostim in the Treatment of Chemotherapy Induced Thrombocytopenia (CIT) in a Patient with Mantle Cell Lymphoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Judit","family":"Demeter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildiko","family":"Istenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anik\u00f3","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Paksi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dombi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Valasiny\u00f3szki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Csomor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Matolcsy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt G.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,14]]},"reference":[{"key":"9276_CR1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/CCO.0b013e32831369b2","volume":"20","author":"B Levy","year":"2008","unstructured":"Levy B, Arnason JE, Bussel JB (2008) The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia. Curr Opin Oncol 20:690\u2013696","journal-title":"Curr Opin Oncol"},{"key":"9276_CR2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S1359-6349(09)71939-1","volume":"7","author":"R Natale","year":"2009","unstructured":"Natale R, Charu V, Sch\u00fctte W et al (2009) Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC). Eur J Cancer Suppl 7:574","journal-title":"Eur J Cancer Suppl"},{"key":"9276_CR3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S1359-6349(09)71900-7","volume":"7","author":"M Fanale","year":"2009","unstructured":"Fanale M, Stiff P, Noonan K et al (2009) Safety of romiplostim for treatment of severe chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma receiving multi-cycle chemotherapy: results from an open-label dose- and schedule-finding study. Eur J Cancer Suppl 7:562","journal-title":"Eur J Cancer Suppl"},{"key":"9276_CR4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00277-006-0087-3","volume":"85","author":"S Dalal","year":"2006","unstructured":"Dalal S, Boddapati M, Lowery MN et al (2006) Treatment of acute myeloid leukemia in a Jehovah\u2019s Witness. Ann Hematol 85:407\u2013408","journal-title":"Ann Hematol"},{"key":"9276_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0268-960X(03)00065-1","volume":"18","author":"MJ Nash","year":"2004","unstructured":"Nash MJ, Cohen H (2004) Management of Jehovah's Witness patients with haematological problems. Blood Rev 18:211\u20137","journal-title":"Blood Rev"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-010-9276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-010-9276-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-010-9276-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:39:13Z","timestamp":1559457553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-010-9276-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,14]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9276"],"URL":"https:\/\/doi.org\/10.1007\/s12253-010-9276-4","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,14]]}}}